George Perry (neuroscientist)

George Perry
Born (1953-04-12) April 12, 1953
Lompoc, California
Residence San Antonio, Texas
Citizenship United States
Alma mater Allan Hancock College, UC Santa Barbara, Hopkins Marine Station of Stanford University and Scripps Institution of Oceanography of UC San Diego
Known for Work on neuronal oxidation of nucleic acids in Alzheimer's disease
Awards Denham Harman Research Award [American Aging Association], Alzheimer Award and Medal (twice) Journal of Alzheimer's Disease, ISI highly cited researcher Fellow, Corresponding Member of Sciences Academy of Lisbon, Spanish Royal Academy of Sciences and Mexican Academy of Sciences, Fellow of Linnean Society of London, Microscopy Society of America, Royal Society of Chemistry, Royal Society of Medicine, Society of Biology, Royal College of Pathologists. & AAAS
Scientific career
Fields Neurology
Institutions Baylor College of Medicine, Case Western Reserve University, U AlaskaU Texas San Antonio
Doctoral advisor David Epel
Other academic advisors Bill Brinkley,
Notable students Paula Moreira, Mark Smith

George Perry (born April 12, 1953 in Lompoc, California) is the Dean of the College of Sciences, Semmes Professor of Neurobiology, and Professor of Biology at the University of Texas at San Antonio. Perry is recognized in the field of Alzheimer's disease research particularly for his work on oxidative stress.

Education

Perry received his Bachelor of Arts degree in Zoology from University of California, Santa Barbara. After graduation, he studied at Scripps Institution of Oceanography, Hopkins Marine Station of Stanford University, and the Marine Biological Laboratory at Woods Hole; he obtained his Ph.D from the University of California at San Diego in Marine Biology under David Epel in 1979. He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of William R. Brinkley, Joseph Bryan and Anthony R. Means at Baylor College of Medicine where he laid the foundation for his observations of cytoskeletal abnormalities.

Professional appointments

In 1982, Perry joined the faculty of Case Western Reserve University, where he holds an adjunct appointment. He is dean of the College of Sciences and professor of biology at the University of Texas at San Antonio . He is distinguished as one of the top Alzheimer’s disease researchers[1][2] with over 1000 publications, one of the top 100 most-cited scientists[3] in Neuroscience & Behavior and one of the top 25 scientists in free radical research.[4] Perry is highly cited (over 52,000 times;H=113;ISI/over 83,000 times;H=145;Google Scholar) and is recognized as an ISI highly cited researcher.[5] Perry is editor for numerous journals. Perry is the current editor-in-chief of Letters in Drug Design & Discovery, a medicinal chemistry journal that is published by Bentham Science Publishers.[6] Perry is also the current editor-in-chief for the Journal of Alzheimer's Disease, an international multidisciplinary journal that specialises in Alzheimer's disease.[7] Perry is also the editor-in-chief of several open-access journals. These include The Open Neurology Journal, which is published by Bentham Open,[8] Journal of Cytology & Histology, which is published by the OMICS Publishing Group[9] and Annual Review & Research in Biology, which is published by ScienceDomain International.[10] Perry is fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, International Engineering and Technology Institute (IETI), Texas Academy of Sciences, past-president and interim executive director of the Southwestern and Rocky Mountain Division of American Association for the Advancement of Sciences, Chair of the Board of the National Organization of Portuguese Americans and past-president of the American Association of Neuropathologists.

Research focus

Perry's research is primarily focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease.[11] He has played a key role in elucidating oxidative damage as the initial cytopathological abnormality in Alzheimer disease. He is currently working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. His current studies focus on two issues: (i) the metabolic basis for the mitochondrial damage restricted to vulnerable neurons; and (ii) the consequences of RNA oxidation on protein synthesis rate and fidelity.

References

  1. ↑ Alzheimer's Disease
  2. ↑ Sorensen, AA. "Alzheimer's disease research: scientific productivity and impact of the top 100 investigators in the field". J Alzheimers Dis. 16: 451–65. doi:10.3233/JAD-2009-1046. PMID 19221406.
  3. ↑ in-cites - The 100 Most-Cited Scientists in Neuroscience
  4. ↑ Lab Registry Archived 2008-08-21 at the Wayback Machine.
  5. ↑ Researcher ID Profile
  6. ↑ "Letters in Drug Design & Discovery Editorial Board". Retrieved 2018-03-20.
  7. ↑ "Journal of Alzheimer's Disease Board". Retrieved 2018-03-20.
  8. ↑ "The Open Neurology Journal Editorial Board". Retrieved 2018-03-25.
  9. ↑ "Journal of Cytology & Histology Editor Profile - George Perry". Retrieved 2018-03-25.
  10. ↑ "Annual Review & Research in Biology Editorial Board". Retrieved 2018-03-25.
  11. ↑ "George Perry Academic Research (UTSA faculty website)". UTSA.edu. Archived from the original on 30 November 2012. Retrieved 9 May 2014.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.